Alumbro, Bernadeth C.
HRN: 22-70-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/14/2023
03/21/2023
IV
2.25g
Q6
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes